Tianci International, Inc. (CIIT): Nasdaq/NYSE listing notice — Tianci International receives Nasdaq bid-price deficiency notice, faces delisting risk

Tianci International, Inc.

Nasdaq notified Tianci on Oct 29, 2025 that common stock bid price below $1.00 for 30 consecutive business days.
Company has 180 calendar days, until April 27, 2026, to regain compliance by closing at $1.00+ for 10 consecutive days.
If not compliant by deadline, Tianci may seek an additional grace period or face delisting with appeal rights.
Management will monitor stock price and consider options to regain compliance.

item 3.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Tianci International, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 5550(a)(2)

Exact text from the filing

October 29, 2025, Tianci received a deficiency letter from the Listing Qualifications Department (the “Staff”) of the Nasdaq Stock Market (“Nasdaq”) notifying Tianci that, for the preceding 30 consecutive business days, the closing bid price for Tianci’s Common Stock was below the minimum $1.00 per share requirement for continued inclusion on The Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(2) (the “Bid Price Requirement”). The notification has no immediate effect on Tianci’s Nasdaq listing. In accordance with Nasdaq rules, Tianci has been provided a period of 180 calendar day

View on SEC.gov

5 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

Tianci International, Inc. filing history →

Source: SEC EDGAR

accession 0001683168-25-007855

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.